Athanassios Argiris, MD
The University of Texas Health Science Center at San Antonio · University of Pittsburgh · Robert H. Lurie Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Athanassios Argiris, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:39 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT01634880 · Postoperative Radiotherapy and Panitumumab in High-Risk Salivary Gland MalignanciesAthanassios Argiris · withdrawn · Salivary Gland Malignancy · principal investigator
- N/ANCT01487733 · Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301Eastern Cooperative Oncology Group · completed · Head and Neck Cancer · principal investigator
- Ph2NCT00492206 · Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLCUniversity of Pittsburgh · completed · Non Small Cell Lung Cancer (NSCLC) · principal investigator
- Ph2NCT00469976 · Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung CancerEastern Cooperative Oncology Group · withdrawn · Lung Cancer · study chair
- Ph1NCT00004097 · Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck CancerNational Cancer Institute (NCI) · unknown · Head and Neck Cancer · study chair
- Ph1/Ph2NCT00073866 · Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung CancerNorthwestern University · completed · Lung Cancer · study chair
- Ph2NCT00062387 · Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck CancerNational Cancer Institute (NCI) · terminated · Head and Neck Cancer · study chair
- Ph2NCT00004094 · Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or LarynxNational Cancer Institute (NCI) · unknown · Head and Neck Cancer · study chair
- Ph2NCT00058006 · Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung CancerNorthwestern University · completed · Head and Neck Cancer, Lung Cancer · study chair
- Ph2NCT00040807 · Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck CancerEastern Cooperative Oncology Group · completed · Head and Neck Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:39 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.